Obesity and related risk of myeloproliferative neoplasms among israeli adolescents

被引:16
|
作者
Leiba, Adi [1 ,2 ,3 ]
Duek, Adrian [2 ,4 ]
Afek, Arnon [2 ]
Derazne, Estela [2 ]
Leiba, Merav [2 ,4 ]
机构
[1] IDF Med Corps, Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Harvard Med Sch, Dept Med, Mt Auburn Hosp, Cambridge, MA USA
[4] Sheba Med Ctr, Dept Hematol & Bone Marrow Transplant, Tel Hashomer, Israel
关键词
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; LIFE-STYLE; MYELOFIBROSIS; ADIPONECTIN;
D O I
10.1002/oby.21863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveObesity has been associated with various malignancies, but a clear association between overweight and myeloproliferative neoplasms (MPN) has not been established. MethodsThis study assessed the association between adolescent obesity and future risk for MPN. Data on 2,516,256 Israeli adolescents, who underwent a compulsory general health examination at ages 16 to 19, between 1967 and 2011, were linked to the National Cancer Registry in this nationwide, population-based cohort study. Cox proportional hazards models were used to estimate the hazard ratio (HR) for MPN associated with BMI measured at adolescence. ResultsThe mean follow-up of 19.8612.15 years reflected 49,977,521 person years, during which 433 examinees developed MPN, primarily chronic myelogenous leukemia, polycythemia vera, and essential thrombocythemia. Obesity (BMI95th percentile) in adolescence significantly predicted increased risk of MPN with HR (adjusted for sex) of 1.81 (95% confidence interval 1.13-2.92, P=0.014). ConclusionsAdolescent obesity might be related to an increased incidence of myeloproliferative neoplasms.
引用
收藏
页码:1187 / 1190
页数:4
相关论文
共 50 条
  • [1] OBESITY AND MYELOPROLIFERATIVE NEOPLASMS: A SYSTEMATIC REVIEW
    Gaman, Mihnea-Alexandr
    Epingeac, Mirela Elena
    Gaman, Amelia Maria
    Diaconu, Camelia Cristina
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E121 - E121
  • [2] Myeloproliferative neoplasms in adolescents and young adults
    Amerikanou, Rodothea
    Lambert, Jonathan
    Alimam, Samah
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (02)
  • [3] Myeloproliferative neoplasms related glomerulopathy
    Paule, R.
    Ponsoye, M.
    Gueutin, V.
    Deray, G.
    Izzedine, H.
    REVUE DE MEDECINE INTERNE, 2013, 34 (06): : 369 - 372
  • [4] Autoimmunity and the risk of myeloproliferative neoplasms
    Kristinsson, Sigurdur Y.
    Landgren, Ola
    Samuelsson, Jan
    Bjorkholm, Magnus
    Goldin, Lynn R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1216 - 1220
  • [5] Incidence and risk factors for second malignancies among patients with myeloproliferative neoplasms
    Zhang, Yuhui
    Han, Yingdi
    Teng, Guangshuai
    Du, Chenxiao
    Gao, Shan
    Yuan, Weiping
    Zhang, Lei
    Bai, Jie
    CANCER MEDICINE, 2023, 12 (08): : 9236 - 9246
  • [6] Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults
    Kucine, Nicole
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 141 - 148
  • [7] Risk taking and coping strategies among Israeli adolescents
    Ben-Zur, H
    Reshef-Kfir, Y
    JOURNAL OF ADOLESCENCE, 2003, 26 (03) : 255 - 265
  • [8] Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults
    Nicole Kucine
    Current Hematologic Malignancy Reports, 2020, 15 : 141 - 148
  • [9] The myeloproliferative neoplasms-related glomerulopathy
    Bardy, A.
    Tiple, A.
    Rabant, M.
    Kemeny, J. -L.
    El Karoui, K.
    Hermet, M.
    Guearot-Imbert, G.
    Deteix, P.
    Bay, J. -O.
    Aumaitre, O.
    Andre, M.
    REVUE DE MEDECINE INTERNE, 2014, 35 (04): : 222 - 230
  • [10] RISK OF LIMPHOPROLIFERATIVE NEOPLASMS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
    Cancio, S.
    Soler, G.
    Miguel Torregrosa, J.
    Caparros, E.
    Osma, M.
    Ortuno, F.
    Luengo-Gil, G.
    Vicente, V.
    Ferrer-Marin, F.
    HAEMATOLOGICA, 2013, 98 : 620 - 620